Hap Trading, LLC Ocugen, Inc. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $23,625 - $41,850	13,500 New	13,500 $18,000
Q1 2022 May 12, 2022	SELL	$2.34 - $4.72 $479,933 - $968,072	-205,100 Reduced 88.25%	27,300 $107,000
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $856,728 - $3.07 Million	195,600 Added 531.52%	232,400 $314,000
Q3 2021 Nov 10, 2021	SELL	$6.36 - $8.51 $216,876 - $290,191	-34,100 Reduced 48.1%	36,800 $123,000
Q2 2021 Aug 11, 2021	BUY	$5.52 - $15.68 $241,223 - $685,216	43,700 Added 160.66%	70,900 $97,000
Q1 2021 May 14, 2021	BUY	$1.66 - $15.81 $45,152 - $430,032	27,200 New	27,200 $53,000

125

78.4M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.